Simultaneous determination of erlotinib and its isomeric major metabolites in human plasma using isocratic liquid chromatography-tandem mass spectrometry and its clinical application.

MLA

Ishida, Takuya, et al. “Simultaneous Determination of Erlotinib and Its Isomeric Major Metabolites in Human Plasma Using Isocratic Liquid Chromatography-Tandem Mass Spectrometry and Its Clinical Application.” Biomedical Chromatography : BMC, vol. 29, no. 5, May 2015, pp. 643–46. EBSCOhost, https://doi.org/10.1002/bmc.3357.

APA

Ishida, T., Naito, T., & Kawakami, J. (2015). Simultaneous determination of erlotinib and its isomeric major metabolites in human plasma using isocratic liquid chromatography-tandem mass spectrometry and its clinical application. Biomedical Chromatography : BMC, 29(5), 643–646. https://doi.org/10.1002/bmc.3357

Chicago

Ishida, Takuya, Takafumi Naito, and Junichi Kawakami. 2015. “Simultaneous Determination of Erlotinib and Its Isomeric Major Metabolites in Human Plasma Using Isocratic Liquid Chromatography-Tandem Mass Spectrometry and Its Clinical Application.” Biomedical Chromatography : BMC 29 (5): 643–46. doi:10.1002/bmc.3357.